G2GBIO지투지바이오
456160 · KOSDAQ · ₩456160 · 지투지바이오
₩37,900▼ ₩1,250 (3.19%)End-of-day · Oct 28, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | |
|---|---|---|---|
| Gross margin | 36.2% | −7.9% | 24.8% |
| Operating margin | −568.7% | −2,884.2% | −1,399.8% |
| Net margin | −674.6% | −2,857.1% | −10,827.3% |
Growth (year on year)
| TTM | 2025 | 2024 | |
|---|---|---|---|
| Revenue growth | +423.7% | −45.0% | — |
| Operating income growth | −3.3% | −13.4% | — |
| Net income growth | −23.6% | +85.5% | — |
Returns
| TTM | 2025 | 2024 | |
|---|---|---|---|
| Return on equity | −15.1% | 39.5% | 69.6% |
| Return on assets | −9.9% | −26.0% | −328.5% |
Leverage and liquidity
| TTM | 2025 | 2024 | |
|---|---|---|---|
| Liabilities to equity | 69.1% | 16.1% | −121.2% |
| Net debt to equity | −57.0% | −73.5% | −0.4% |
| Current ratio | 237.6% | 735.3% | 7.6% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: G2GBIO / 지투지바이오 / 456160 / KRX:456160
Source: KRX statistical information